BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1692931)

  • 1. Effects of beta 1- and beta 2-adrenoceptor stimulation on hemodynamics in the anesthetized rat.
    Abdelrahman A; Tabrizchi R; Pang CC
    J Cardiovasc Pharmacol; 1990 May; 15(5):720-8. PubMed ID: 1692931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Celiprolol: agonist and antagonist effects at cardiac beta 1- and vascular beta 2-adrenoceptors determined under in vivo conditions in the rat.
    Alvarez-Guerra M; Alda O; Garay RP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jun; 355(6):689-98. PubMed ID: 9205952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
    Nichols AJ; Gellai M; Ruffolo RR
    Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.
    Malinowska B; Schlicker E
    Br J Pharmacol; 1996 Mar; 117(5):943-9. PubMed ID: 8851515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of beta1 and beta2 adrenoceptors in isoproterenol-induced drinking.
    Kirby RF; Novak CM; Thunhorst RL; Johnson AK
    Brain Res; 1994 Sep; 656(1):79-84. PubMed ID: 7804848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
    Smith HJ; Halliday SE; Earl DC; Stribling D
    J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of beta adrenoceptor agonists and antagonists on the rat ovarian suspensory ligament.
    Stanton HC; Dungan KW
    J Pharmacol Exp Ther; 1986 Nov; 239(2):591-6. PubMed ID: 2877087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodepressor reaction induced by inferior vena cava occlusion and isoproterenol in the rat. Role of beta 1- and beta 2-adrenergic receptors.
    Waxman MB; Asta JA; Cameron DA
    Circulation; 1994 May; 89(5):2401-11. PubMed ID: 7910121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
    Kroeger RJ; Groszmann RJ
    Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the alpha agonist activity of dobutamine in mediating cardiac output: effects of prolonged isoproterenol infusion.
    Hayes JS; Bowling N
    J Pharmacol Exp Ther; 1987 Jun; 241(3):861-9. PubMed ID: 2885411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
    Beaulieu G; Grimes D; Muirhead C; Oshiro G
    Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta adrenoceptor agonists and antagonists on adrenal catecholamine release in response to splanchnic nerve stimulation in anesthetized dogs: role of beta-1 and beta-2 adrenoceptors.
    Koganei H; Kimura T; Satoh S
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1337-44. PubMed ID: 7791106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.
    Liu YL; Cawthorne MA; Stock MJ
    Br J Pharmacol; 1996 Mar; 117(6):1355-61. PubMed ID: 8882636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An effect of extrarenal beta adrenergic stimulation on the release of renin.
    Reid IA; Schrier RW; Earley LE
    J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.